InvestorsHub Logo
icon url

Poor Man -

12/12/21 9:16 PM

#426083 RE: CrashOverride #426075

Red, I agree with much of your points - sans the bag thingy.

Seriously, DI needs to reach out to large investors this week. There’s simply too much uncertainty combined with other factors about this stock that’s lending itself to an implosion. I can’t image your investors are sitting too happy at this stage.

The Old Crow got me through the weekend. Maybe be I’ll buy a case for the holiday season.
icon url

Maverick0408

12/13/21 3:35 AM

#426099 RE: CrashOverride #426075

To add to this, why would LL fight this late in the game (with her presentations during the spring at Mt Sinai amongst others) if the data wasn’t impressive? Also, remember the podcast KA did in May!

Plus LL getting inducted in Asian Hall of Fame for her work on brain cancer vaccine last month.

We must remember that UK and EU have accepted new endpoints and approvals in those regions are over 90% certain. That alone gets us to a 2-3 billion market cap minimum. If our (US) clinical trials website gets updated with our new endpoints in Q1, we deserve a market cap of close to 5 billion, IMO.

I believe TLD+publication will to be released in Q1. If it doesn’t then I start to question their intent. Not sure many shareholders will stick around any longer regardless of what they say about Flaskworks and it’s potential.

Either way, if they are not acquired in 2022 I am not sure this management will be able to fulfill the tremendous promise this vaccine offers. Again, I say time is money. With the promise of AI amongst other things, a company like Merck can really take this to another level.

icon url

HappyLibrarian

12/13/21 10:31 AM

#426202 RE: CrashOverride #426075

Dr. Liau would tell patients to freeze their tumors because of compassionate use and her own work at UCLA which continues even as NWBO has barely moved.

NWBO is not advertising and that is part of the problem. They probably do not know how. Tote bags for a SNO scarcely count as even a half-hearted step and the share price reflects that. By advertising I mean what NWBO can legally do pre-approval.

Look at the terms of the deal with Fife. Does he really stand to lose all $15 million or are there ways he can hedge? At a minimum Fife would be well senior to us in getting any chunk of NWBO’s remaining assets and he knows that Linda Powers is good at keeping NWBO going indefinitely without ever producing the goods so putting up more money, for which he is handsomely rewarded may not mean what we think. This person is a known toxic financier.

Historical controls make sense and should have been agreed to long ago. The lab models the real world where’s historical controls are the real world. The FDA’s decision may or may not be inspired by NWBO or be enough to help.